EGFR and central nervous system cancer: TF expression has also been shown to be modulated in other cancers by constitutively active mutant forms of epidermal growth factor receptor (EGFRvIII) in glioma and vulva cells, as well as Src family kinases, TGF-β production, and hypoxia [40].